Detalles de la búsqueda
1.
EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.
Ann Rheum Dis
; 81(6): 768-779, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35110331
2.
Lipid management in systemic lupus erythematosus according to risk classifiers suggested by the European Society of Cardiology and disease-related risk factors reported by the EULAR recommendations.
RMD Open
; 9(1)2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36759009
3.
Application of EULAR and European Society of Cardiology recommendations with regard to blood pressure and lipid management in antiphospholipid syndrome.
RMD Open
; 9(3)2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37558493
4.
Cardiovascular risk assessment in patients with antiphospholipid syndrome: a cross-sectional performance analysis of nine clinical risk prediction tools.
RMD Open
; 9(4)2023 11 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38016710
5.
Generic and disease-adapted cardiovascular risk scores as predictors of atherosclerosis progression in SLE.
Lupus Sci Med
; 10(1)2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36868585
6.
Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus.
Eur J Prev Cardiol
; 28(3): 346-352, 2021 04 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33891687
7.
Underperformance of clinical risk scores in identifying vascular ultrasound-based high cardiovascular risk in systemic lupus erythematosus.
Eur J Prev Cardiol
; : 2047487320906650, 2020 Mar 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32122200
8.
Pulse pressure amplification and cardiac autonomic dysfunction in patients with type 2 diabetes mellitus.
J Hum Hypertens
; 32(8-9): 531-539, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29789692
Resultados
1 -
8
de 8
1
Próxima >
>>